Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRTX | AZN | AMGN | GILD | BMY |
| Company | Mirati Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 58.86 | 185.99 | 336.22 | 135.13 | 57.00 |
| High | 58.99 | 187.10 | 337.51 | 137.20 | 57.33 |
| Low | 58.54 | 184.65 | 333.06 | 133.54 | 56.54 |
| Latest | 58.70 | 185.67 | 336.79 | 134.43 | 57.18 |
| Change | -0.10 | +0.34 | +0.31 | -1.79 | +0.27 |
| % Change | -0.17% | +0.18% | +0.09% | -1.31% | +0.47% |
| Volume | 20,994,400 | 1,499,200 | 2,954,400 | 17,510,201 | 27,567,500 |
| 20-Day Average Volume | 2,385,220 | 1,796,575 | 2,678,355 | 6,676,685 | 10,724,835 |
| Previous Close | 58.80 | 185.33 | 336.48 | 136.22 | 56.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 58.94 | 184.85 | 332.44 | 132.82 | 57.33 |
| 20-Day Raw Stochastic | 17.39% | 49.30% | 69.89% | 66.48% | 36.64% |
| 20-Day Relative Strength | 61.06 | 46.13 | 47.93 | 50.08 | 46.85 |
| Weighted Alpha | -3.70 | +22.64 | +14.13 | +19.51 | +19.12 |
| Today's Opinion | 88% Buy | 8% Sell | 8% Sell | 8% Buy | Hold |
| Previous Opinion | 88% Buy | 8% Sell | 8% Sell | 24% Buy | Hold |
| Last Month's Opinion | 100% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.98% since 01/12/24 | -2.15% since 05/21/26 | -0.19% since 05/21/26 | +3.01% since 05/21/26 | -3.98% since 05/21/26 |
| Low | 58.54 on 01/22/24 | 183.35 on 05/28/26 | 333.06 on 05/29/26 | 131.12 on 05/22/26 | 56.26 on 05/28/26 |
| High | 59.27 on 01/16/24 | 189.08 on 05/22/26 | 343.80 on 05/22/26 | 137.20 on 05/29/26 | 60.25 on 05/22/26 |
| 1-Month | |||||
| %Chg | -0.41% since 12/22/23 | +0.25% since 04/29/26 | -0.36% since 04/29/26 | +4.34% since 04/29/26 | -0.71% since 04/29/26 |
| Low | 58.54 on 01/22/24 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.96 on 04/30/26 | 55.40 on 05/11/26 |
| High | 59.46 on 01/12/24 | 191.50 on 05/21/26 | 349.54 on 04/30/26 | 137.50 on 05/12/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +5.42% since 10/20/23 | -10.93% since 02/27/26 | -13.23% since 02/27/26 | -9.75% since 02/27/26 | -8.32% since 02/27/26 |
| Low | 55.14 on 10/27/23 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 59.46 on 01/12/24 | 207.30 on 04/10/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +87.48% since 07/21/23 | +0.12% since 11/28/25 | -2.51% since 11/28/25 | +6.83% since 11/28/25 | +16.22% since 11/28/25 |
| Low | 27.30 on 08/08/23 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 64.41 on 10/06/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,117,688 | 287,957,088 | 181,768,256 | 166,904,240 | 116,765,616 |
| Shares Outstanding, K | 70,148 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 12,440,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -740,870,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 16,400,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -161,900,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.77 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.49 on 11/06/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 02/27/24 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.01 | 15.23 | 16.27 | 9.60 |